73866 Federal Register / Vol. 88, No. 207 / Friday, October 27, 2023 / Notices 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: October 23, 2023. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–23748 Filed 10–26–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; (SEP): 

Neurotechnology and Eye Diseases. 

Date: November 21, 2023. 

Time: 12:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Lai Yee Leung, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 1011D, 

Bethesda, MD 20892, (301) 827–8106, 

leungl2@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR/RFA 

Panel: Animal and Biological Material 

Resource Centers and Resource-Related 

Research Projects. 

Date: November 28–29, 2023. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Rolf Jakobi, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6190, 

MSC 7806, Bethesda, MD 20892, 301–435– 

1718, jakobir@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR–23– 

137: Science Education Partnership Award 

(SEPA) R25. 

Date: November 29–30, 2023. 

Time: 10:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: James J Li, Ph.D., Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 5148, MSC 7849, Bethesda, MD 

20892, 301–806–8065, lijames@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Topics in 

Basic Cancer Immunology. 

Date: November 29, 2023. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Sarita Kandula Sastry, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20782, 301–402–4788, sarita.sastry@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: October 23, 2023. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–23746 Filed 10–26–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Advancing 

Translational Sciences; Notice of 

Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Advancing Translational Sciences Special 

Emphasis Panel; Rare Disease Clinical Trial 

Readiness. 

Date: February 15, 2024. 

Time: 10:00 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Center for Advancing 

Translational Sciences, National Institutes of 

Health, 6701 Democracy Boulevard, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Jing Chen, Ph.D., Scientific 

Review Officer, Office of Scientific Review, 

National Center for Advancing Translational 

Sciences, National Institutes of Health, 6701 

Democracy Boulevard, Room 1080, Bethesda, 

MD 20892, (301) 827–3268, chenjing@

mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.350, B—Cooperative 

Agreements; 93.859, Biomedical Research 

and Research Training, National Institutes of 

Health, HHS) 

Dated: October 23, 2023. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–23750 Filed 10–26–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Coast Guard 

[Docket No. USCG–2023–0292] 

National Chemical Transportation 

Safety Advisory Committee Meeting; 

November 2023 Meeting 

AGENCY: Coast Guard, Department of 

Homeland Security. 

ACTION: Notice of cancellation. 

SUMMARY: The meeting of the National 

Chemical Transportation Safety 

Advisory Committee scheduled for 

November 28 through 30, 2023, from 9 

a.m. until 5 p.m. Central Standard Time 

(CST) is cancelled. 

DATES: The cancelled meeting was 

announced in the Federal Register on 

Tuesday, October 10, 2023, at 88 FR 

69936. 

FOR FURTHER INFORMATION CONTACT: 

Lieutenant Ethan T. Beard, Alternate 

Designated Federal Officer of the 

National Chemical Transportation 

Safety Advisory Committee, telephone, 

(202) 372–1419, or email 

Ethan.T.Beard@uscg.mil. 

SUPPLEMENTARY INFORMATION: The 

Committee acts solely in an advisory 

capacity to the Secretary of the 

Department of Homeland Security 

through the Commandant of the Coast 

Guard and the Director of Commercial 

Regulations and Standards on matters 

related to the safe and secure marine 

transportation of hazardous materials. 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 88, No. 207 / Friday, October 27, 2023 / Notices 73867 

Notice of cancellation of this meeting 

is given under the Federal Advisory 

Committee Act (5 U.S.C., ch. 10). 

Dated: October 23, 2023. 

Benjamin J. Hawkins, 

Acting Director of Commercial Regulations 

and Standards. 

[FR Doc. 2023–23691 Filed 10–26–23; 8:45 am] 

BILLING CODE 9110–04–P 

DEPARTMENT OF HOMELAND 

SECURITY 

U.S. Customs and Border Protection 

[OMB Control Number 1651–0009] 

Agency Information Collection 

Activities; Revision of Existing 

Collection; U.S. Customs Declaration 

(CBP Form 6059B) 

AGENCY: U.S. Customs and Border 

Protection (CBP), Department of 

Homeland Security. 

ACTION: 30-Day Notice and request for 

comments. 

SUMMARY: U.S. Customs and Border 

Protection (CBP), Department of 

Homeland Security, will be submitting 

the following information collection 

request to the Office of Management and 

Budget (OMB) for review and approval 

in accordance with the Paperwork 

Reduction Act of 1995 (PRA). The 

information collection is published in 

the Federal Register to obtain comments 

from the public and affected agencies. 

DATES: Comments are encouraged and 

must be submitted (no later than 

November 27, 2023) to be assured of 

consideration. 

ADDRESSES: Written comments and/or 

suggestions regarding the item(s) 

contained in this notice should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

FOR FURTHER INFORMATION CONTACT: 

Requests for additional PRA information 

should be directed to Seth Renkema, 

Chief, Economic Impact Analysis 

Branch, U.S. Customs and Border 

Protection, Office of Trade, Regulations 

and Rulings, 90 K Street NE, 10th Floor, 

Washington, DC 20229–1177, 

Telephone number 202–325–0056 or via 

email CBP_PRA@cbp.dhs.gov. Please 

note that the contact information 

provided here is solely for questions 

regarding this notice. Individuals 

seeking information about other CBP 

programs should contact the CBP 

National Customer Service Center at 

877–227–5511, (TTY) 1–800–877–8339, 

or CBP website at https://www.cbp.gov/. 

SUPPLEMENTARY INFORMATION: CBP 

invites the general public and other 

Federal agencies to comment on the 

proposed and/or continuing information 

collections pursuant to the Paperwork 

Reduction Act of 1995 (44 U.S.C. 3501 

et seq.). This proposed information 

collection was previously published in 

the Federal Register (88 FR 13452) on 

March 03, 2023, allowing for a 60-day 

comment period. This notice allows for 

an additional 30 days for public 

comments. This process is conducted in 

accordance with 5 CFR 1320.8. Written 

comments and suggestions from the 

public and affected agencies should 

address one or more of the following 

four points: (1) whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; (2) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; (3) 

suggestions to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) suggestions to 

minimize the burden of the collection of 

information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology, e.g., permitting 

electronic submission of responses. The 

comments that are submitted will be 

summarized and included in the request 

for approval. All comments will become 

a matter of public record. 

Overview of This Information 

Collection 

Title: U.S. Customs Declaration. 

OMB Number: 1651–0009. 

Form Number: 6059B. 

Current Actions: CBP is submitting a 

revision package to terminate the APC 

Program, announce MPC Expansion, 

and add the CBP One Mobile 

Application to the collection. 

Type of Review: Revision. 

Affected Public: Individuals. 

Abstract: CBP Form 6059B, Customs 

Declaration, is used as a standard report 

of the identity and residence of each 

person arriving in the United States. 

This form is also used to declare 

imported articles to U.S. Customs and 

Border Protection (CBP) in accordance 

with 19 CFR 122.27, 148.12, 148.13, 

148.110, 148.111; 31 U.S.C. 5316 and 

Section 498 of the Tariff Act of 1930, as 

amended (19 U.S.C. 1498). 

Section 148.13 of the CBP regulations 

prescribes the use of the CBP Form 

6059B when a written declaration is 

required of a traveler entering the 

United States. Generally, written 

declarations are required from travelers 

arriving by air or sea. Section 148.12 

requires verbal declarations from 

travelers entering the United States. 

Generally, verbal declarations are 

required from travelers arriving by land. 

CBP continues to find ways to 

improve the entry process through the 

use of mobile technology to ensure it is 

safe and efficient. To that end, CBP has 

deployed a process which allows 

travelers to use a mobile app to submit 

information to CBP prior to arrival in 

domestic locations and prior to 

departure at preclearance locations. 

This process, called Mobile Passport 

Control (MPC) allows travelers to selfsegment upon arrival into the United 

States or departing a preclearance 

location. The MPC process also helps 

determine under what circumstances 

CBP should require a written customs 

declaration (CBP Form 6059B) and 

when it is beneficial to admit travelers 

who make an oral customs declaration 

during the primary inspection. MPC 

eliminates the administrative tasks 

performed by the officer during a 

traditional inspection and in most cases 

will eliminate the need for respondents/ 

travelers to fill out a paper declaration. 

MPC provides a more efficient and 

secure in person inspection between the 

CBP Officer and the traveler. 

Another electronic process that CBP 

has in lieu of the paper 6059B is the 

Automated Passport Control (APC). This 

is a CBP program that facilitates the 

entry process for travelers by providing 

self-service kiosks in CBP’s Primary 

Inspection area that travelers can use to 

make their declaration. 

Both APC and MPC allow an 

electronic method for travelers to 

answer the questions that appear on 

form 6059B without filling out a paper 

form. APC program will continue to 

collect this information until the 

program is terminated on September 30, 

2023. 

A sample of CBP Form 6059B can be 

found at: https://www.cbp.gov/ 

newsroom/publications/ 

forms?title=6059. 

This collection is available in the 

following languages: English, French, 

Vietnamese, German, Italian, Japanese, 

Korean, Polish, Portuguese, Russian, 

Chinese, Hebrew, Spanish, Dutch, 

Arabic, Farsi, and Punjabi. 


ddrumheller on DSK120RN23PROD with NOTICES1